Stefania Napolitano

7PUBLICATIONS
47CO-AUTHORS
Cancer geneticsGene and molecular therapyMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 08, 2026
Reprogramming of Cellular Plasticity via ETS and MYC Core-Regulatory Circuits during Response to MAPK Inhibition in BRAF-Mutant Colorectal Cancer.

|Apr 03, 2026
Pembrolizumab for high TMB castration-resistant prostate cancer: A precision medicine case report.

Vincenzo Terrano, Erica Perri, Chiara Cioffo

|Sep 13, 2024
Epigenome Reprogramming Through H3K27 and H3K4 Trimethylation as a Resistance Mechanism to DNA Methylation Inhibition in BRAFV600E-Mutated Colorectal Cancer.

Hey Min Lee, Ajay Kumar Saw, Van K Morris

|Aug 29, 2024
Overexpression of CCL-20 and CXCL-8 genes enhances tumor escape and resistance to cemiplimab, a programmed cell death protein-1 (PD-1) inhibitor, in patients with locally advanced and metastatic cutaneous squamous cell carcinoma.

Vincenzo De Falco, Stefania Napolitano, Renato Franco

|Oct 12, 2023
Novel Clinical Tool to Estimate Risk of False-Negative KRAS Mutations in Circulating Tumor DNA Testing.

Stefania Napolitano, Aparna R Parikh, Jason Henry

|Apr 11, 2023
Antitumor Efficacy of Dual Blockade with Encorafenib + Cetuximab in Combination with Chemotherapy in Human BRAFV600E-Mutant Colorectal Cancer.

Stefania Napolitano, Melanie Woods, Hey Min Lee

Pageof 2

Frequent Collaborators

4 joint publications

Van Morris

4 joint publications

Scott Kopetz

3 joint publications

Teresa Troiani

3 joint publications

Preeti Marie Kanikarla